Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CLDN4/Claudin-4 Antibody (SAA0509), PE

Catalog #:   FHA19612 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, FCM, WB
Accession: O14493
Overview

Catalog No.

FHA19612

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Conjugation

PE

Applications

ELISA, FCM, WB

Target

CPER, CLDN4, Williams-Beuren syndrome chromosomal region 8 protein, CPE-R, CPE-receptor, WBSCR8, Claudin-4, Clostridium perfringens enterotoxin receptor, CPETR1

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

O14493

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0509

Note

For research use only.

Data Image
References

Molecular characterization of cultured adult human liver progenitor cells., PMID:19874131

Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure., PMID:20131287

Twist is inversely associated with claudins in germ cell tumors of the testis., PMID:20718715

The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin., PMID:21105580

Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4., PMID:21115905

C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin., PMID:21123456

[Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells]., PMID:21223796

Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells., PMID:21430244

Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions., PMID:21488172

Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer., PMID:21508375

Laboratory methods in the study of endometrial Claudin-4., PMID:21717364

Anti-claudin-4-conjugated highly luminescent nanoparticles as biological labels for pancreatic cancer sensing., PMID:21717374

Ligation of CD24 expressed by oral epithelial cells induces kinase dependent decrease in paracellular permeability mediated by tight junction proteins., PMID:21806966

M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses., PMID:22413871

Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan., PMID:22681978

Targeting claudin-4 in human pancreatic cancer., PMID:22800288

Claudin expression in breast cancer: high or low, what to expect?, PMID:22936447

Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases., PMID:23097631

Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells., PMID:23563899

Expression patterns of tight junction components induced by CD24 in an oral epithelial cell-culture model correlated to affected periodontal tissues., PMID:23713517

Enteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine., PMID:24603700

Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy., PMID:25118216

Ductal adenocarcinoma of the pancreas usually retained SMAD4 and p53 protein status as well as expression of epithelial-to-mesenchymal transition markers and cell cycle regulators at the stage of liver metastasis., PMID:25119169

Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells., PMID:25744656

Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model., PMID:26139628

Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer., PMID:26342407

Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma., PMID:26464161

Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity., PMID:26526513

Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases., PMID:27687058

Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibody., PMID:27713828

Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancer., PMID:28415141

Impaired Barrier Function and Autoantibody Generation in Malnutrition Enteropathy in Zambia., PMID:28750860

Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients., PMID:29045505

Acanthamoeba (T4) trophozoites cross the MDCK epithelium without cell damage but increase paracellular permeability and transepithelial resistance by modifying tight junction composition., PMID:29097064

Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization., PMID:29856790

Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer., PMID:30647838

Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer., PMID:31040910

Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas., PMID:31498559

BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition., PMID:31919242

Targeting claudin-4 enhances chemosensitivity in breast cancer., PMID:32086991

HMGB1 enhances epithelial permeability via p63/TGF-β signaling in lung and terminal bronchial epithelial cells., PMID:32857676

Innovative and Highly Sensitive Detection of Clostridium perfringens Enterotoxin Based on Receptor Interaction and Monoclonal Antibodies., PMID:33917845

Claudins and Gastric Cancer: An Overview., PMID:35053454

Expression of Claudin-4 and D2-40 and their significance in prostatic adenocarcinoma., PMID:38384059

Claudin-4: A New Molecular Target for Epithelial Cancer Therapy., PMID:36982569

Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment., PMID:38886509

Comparison of Claudin-4, BerEP4, Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin-4 at Low Cellularity., PMID:39138853

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review)., PMID:39301632

Robust immune responses to intranasal vaccine targeting Bordetella pertussis antigens to claudin-4 on mucosal microfold cells., PMID:40220802

p38 MAPK-mediated upregulation of claudin-3 and claudin-4 by gemcitabine contributes to chemoresistance in ovarian cancer., PMID:40403836

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CLDN4/Claudin-4 Antibody (SAA0509), PE [FHA19612]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2026 AntibodySystem All Rights Reserved.            All Products are for Research Use Only